Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts ...

IBD affects millions of Americans. It's estimated that 130,000 adults and children in New England are living with the disease ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) announced promising topline data from its Phase 2b ANTHEM-UC clinical trial evaluating icotrokinra (JNJ-2113) as a treatment for moderately to severely active ...

Shares of LianBio (NASDAQ:LIAN – Get Free Report) traded down 2.1% during mid-day trading on Friday . The company traded as low as $0.20 and last traded at $0.20. 14,001 shares were traded during ...

Numerous studies have looked at the effect of probiotics on this most common form of eczema. Overall, the evidence suggests ...

Tim Story, a Mississippi football coach, was given months to live after late-stage colon cancer. He enrolled in a clinical ...

Inflammatory bowel disease is a diverse disease that affects people all over the globe. This diversity in setting and treatment options makes it difficult for researchers to estimate the exact cost of ...

Novo Nordisk announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche announced a ...

Palisade Bio (PALI) provided an update on its ongoing Phase 1a/b study of PALI-2108 for the treatment of Ulcerative Colitis, UC. The Company ...

You can test for lactose intolerance at home or through a provider. This article covers testing accuracy and helps you ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report)‘s stock had its “market perform” rating reissued by analysts at William ...

Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel therapeutics that target molecular mechanisms of regulated cell death for immune mediated ...